Christopher Gibson Sells 50,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of Recursion Pharmaceuticals stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total value of $421,000.00. Following the completion of the transaction, the chief executive officer now directly owns 758,738 […]

Related Keywords

Canada ,Christopher Gibson ,Nasdaq ,Securities Exchange Commission ,Advisor Group ,Recursion Pharmaceuticals Inc ,Needham Company ,Recursion Pharmaceuticals ,First Horizon Advisors Inc ,Keycorp ,Recursion Pharmaceuticals Stock Performance ,Capital Management Inc ,Quarter For Recursion Pharmaceuticals ,Recursion Pharmaceuticals Company Profile ,News Ratings For Recursion Pharmaceuticals Daily ,Benjaminf Edwards Company Inc ,Institutional Investors Weigh In On Recursion Pharmaceuticals ,National Bank ,Get Free Report ,Exchange Commission ,Horizon Advisors ,Recursion Pharmaceuticals Daily ,